statin therapy in the primary prevention of early atrial fibrillation after coronary artery bypass grafting

Clicks: 309
ID: 221036
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #24 of 437 articles by views in renewable energy

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 437 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Objective: Assessment of the role of statin therapy in the prevention of postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) in patients without prior atrial fibrillation. Methods: A retrospective analysis of 206 patients, aged 57.2 ± 7.9 years (mean ± SD), who underwent isolated CABG is carried out. All patients are divided into two groups. The first group (nSt-patients) includes the patients who did not receive statin therapy prior to CABG (n = 82). The second group (St-patients) includes the patients who received statin therapy prior to CABG (n = 124). Both groups received the statin therapy from the first day after CABG. The risk of occurrence of POAF is evaluated using the Cox-regression model. Results: The rate of POAF was 25.6% in nSt-patients and 6.5% in St-patients (P = 0.020). On the 4th day after CABG, white blood cells (WBC) count was 11.0 (9.0, 13.0) × 109/mL (medians with inter-quartile ranges) in nSt-patients and 9.0 (7.6, 10.2) × 109/mL in St-patients (P < 0.001). The peak WBC numbers occurred on the day of POAF onset. The Cox-regression analysis shows that only two factors (statin therapy and number of grafts) had significant influence on the POAF onset. Odds ratio of POAF event prediction by statin therapy was 0.20 (95%CI: 0.08–0.51), P < 0.001. Each subsequent graft increased the risk of POAF in 2.1 times. Conclusion: Statin therapy carried out prior to the CABG is an effective approach to primary prevention of POAF in early postoperative period. Statin therapy after CABG in nSt-patients does not give prophylactic effect observed in St-patients.
Reference Key
bockeria2016indianstatin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;O.L. Bockeria;V.A. Shvartz;A.A. Akhobekov;A.R. Kiselev;M.D. Prokhorov;E.Z. Golukhova;L.A. Bockeria
Journal renewable energy
Year 2016
DOI
10.1016/j.ihj.2016.04.002
URL
http://www.sciencedirect.com/science/article/pii/S0019483216300219
Keywords
Risk factors Atrial fibrillation coronary artery bypass grafting early postoperative periodsurgerydiseases of the circulatory (cardiovascular) system

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.